CTRI/2017/12/010930Completed未知
Efficacy and Safety of Lactase in Infantile Colic: A Randomized Placebo Controlled Trial
Walter Bushnell Laboratories Private Limited0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Apparently clinically healthy infant who is <5 months of age with infantile colic with no evidence of failure to thrive, fever or illness
Exclusion Criteria
- •Infants born < 34 weeks, or with birth weight < 2500 grams or inadequate weight gain (125 grams/week); gastrointestinal disorders; previous abdominal surgery; acute illness; anaphylaxis; galactosemia and diabetes mellitus.
Investigators
Similar Trials
Completed
Phase 2
Survey in efficacy of probiotics in infantile colicInfantile colic.Disorders of other specified digestive organs in diseases classified elsewhereIRCT201409015330N8VICE-CHANCELLOR FOR RESEARCH OF TABRIZ UNIVERCITY OF MEDICAL SCIENCES60
Terminated
Not Applicable
Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding InfantsInfantile ColicNCT03477669University of Nebraska1
Completed
Not Applicable
Effectiveness of lactase enzyme in subjects with lactase non-persistenceAdult-type hypolactasiaNutritional, Metabolic, EndocrineLactose intoleranceISRCTN55840353Oy Verman Ab (Finland)92
Not yet recruiting
Phase 2
actase enzyme drops use in infant colicCTRI/2024/06/068617Dr Kaithi Pavani
Active, not recruiting
Phase 2
Trial of lactose supplementation in CDGCongenital disorder of glycosylationJPRN-jRCTs061200059Maegaki Yoshihiro5